A Blood Inflammatory Signature Independently Predicts Treatment Failure after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Maria Baez Vientos, Natalia Tijaro Ovalle, Moataz Ellithi, Ilan Goldstein, Amethyst Saldia, Jonathan U. Peled, Pulkit Jain, Esperanza Bouza Papadopoulos, Doris M. Ponce, Brian C. Shaffer, Roni Tamari, James W. Young
+16 more Ioannis Politikos, Mohammad Alhomoud, Gagan Raju, Parastoo Bahrami Dahi, Aaron D. Goldberg, Ellin Berman, Xin Wang, Susan DeWolf, Eytan M. Stein, Fei Teng, Ann Alice Jakubowski, Richard Jirui Lin, Miguel‐Angel Perales, Sergio A. Giralt, Roni Shouval, Sandeep Raj
DOI: 10.1016/j.jtct.2025.12.557
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S388–S388
Publication date
1 February 2026
Language
EN